RegisterLogin

AU-461

CAT: 0804-HY-165498Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-165498Size:1 Each
Selected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
AU-461 is an orally active and reversible inhibitor of the gastric H⁺/K⁺ ATPase with IC₅₀ values for rabbit-derived and pig-derived enzymes are 12.15 μM and 4.20 μM respectively. AU-461 competes with activated cationic K⁺ (Kᵢ = 1.64 μM) . AU-461 reduces both histamine-stimulated gastric acid secretion and basal gastric acid secretion in rats. AU-461 inhibits ulcer formation caused by ethanol or sodium hydroxide, and restores the plasma gastrin level to normal. AU-461 can be used for the study of peptic ulcers[1].
CAS Number
[220854-06-8]
UNSPSC
12352005
Target
Na+/K+ ATPase
Related Pathways
Membrane Transporter/Ion Channel
Field of Research
Metabolic Disease
Smiles
CC1=C(N2C3=C(CC2)C(NCCO)=NC4=C3C=CC=C4OCC(F)(F)F)C=CC(OC)=C1
Molecular Formula
C23H24F3N3O3
Molecular Weight
447.45
References & Citations
[1]Cheon HG, et al. Pharmacological properties of the gastric H (+) /K (+) ATPase inhibitor, AU-461. Pharmacology. 2000 Apr;60 (3) :161-8.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-16620DF 461
HY-107163CS 461
HY-13214AM-461
HY-145388-01AU-15330
HY-165489AU-006
HY-16372-01CP 461
HY-165569AU-1421
HY-149879Npx-Au
HY-163410-01AU-24118
HY-U00020-01AU-224

Alternative Products

CatalogName
MBS5812346AU-461
T69801-01AU-461
T71244-01AM-461
MBS5780641CP 461
MBS5775051DF-461
A8720-25MYK-461
T31104CS 461
HE186005-2KAu-PEG-NH2 (Au:15nm), 2K
M34553-01CP 461
BUP08134-01CP 461

Popular Products